An interventional study of EEG monitoring in Depression, sponsored by Brainmarc Ltd.. Completed at 2 sites in Israel. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-26.
Sponsored by Brainmarc Ltd. · Not applicable, Interventional, and Diagnostic
This study evaluates the use of brain activity monitoring for early identification of pharmaceutical treatment efficacy and development of depression deterioration events.
The study will be conducted in two arms:
In arm I, participants diagnosed with depression. In arm II, healthy participants.
Arm I - Participants that need to start or switch their pharmacological antidepressant therapy will be recruited. Their clinical status will be evaluated and their EEG characteristics will be collected.
Arm II - Clinical and EEG characteristics of Healthy volunteers will collected on a similar timetable.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 37 is below the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →Brainmarc Ltd. is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Additional Inclusion Criteria for Arm I
time or changing dose or changing type of current pharmaceutical treatment or addition to
drug of current pharmaceutical treatment.
Additional Inclusion Criteria for Arm II
Brief Symptom Inventory (BSI \< 2.3).
Exclusion Criteria:
The participant may not enter the study if ANY of the following apply:
or dependence.
EEG monitoring and evaluation
Device: EEG monitoring
EEG monitoring and evaluation
Device: EEG monitoring
EEG evaluation will be done using two off the shelf EEG devices for research and consumer use. The first one is a device called MindWave by NeuroSky ltd (http://neurosky.com) the second called EPOC by Emotiv ltd (https://emotiv.com/epoc.php). EEG evaluation will be conducted for a total duration of 20 minutes with and without auditory stimulation. The auditory stimulation will be performed using standard headphone or earphones to reduce external noises.
Tuning and evaluation of use of EEG analysis of brain prefrontal activity for mental status evaluation.
Outcome measures: optimal EEG device, sampling duration, frequency, and EEG measure dynamics correlation with depression clinical dynamics.
Time frame: 12 months
This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brainmarc Ltd.